SGEN Financial Facts

Research and development: 85.74M
Revenue from collaboration and license agreements: 14.39M
See Full Income Statement

Total current assets: 354.12M
Accumulated deficit: -875.64M
See Full Balance Sheet

Seattle Genetics Inc. (SGEN) Earnings

  |   Expand Research on SGEN
Next EPS Date 10/30/15 *Est. EPS Growth Rate -171.4% *Last Qtr.
Average EPS % Beat Rate +12.7% Revenue Growth Rate +12.9% *Last Qtr.
Average % Move 1-Wk after EPS +2.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/30/15 Q215 -$0.38-$0.26 -$0.12$77.1M$77.97M N/A Details
2/10/15 Q414 -$0.22-$0.25 +$0.03$74.3M$68.34M N/A Details
10/30/14 Q314 -$0.13-$0.24 +$0.11$75.8M$66.9M N/A Details
7/31/14 Q214 -$0.14-$0.23 +$0.09$68.3M$65.04M N/A Details
5/1/14 Q114 -$0.13-$0.21 +$0.08$68.3M$64.62M N/A Details
2/11/14 Q413 -$0.13-$0.24 +$0.11$67.4M$59.5M N/A Details
11/5/13 Q313 -$0.19-$0.22 +$0.03$57.8M$57.79M N/A Details
7/31/13 Q213 -$0.06-$0.19 +$0.13$73.6M$57.15M N/A Details